Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study ; volume:12 ; number:2 ; day:22 ; month:12 ; year:2020 ; pages:509-525 ; date:2.2021
Diabetes therapy ; 12, Heft 2 (22.12.2020), 509-525, 2.2021
- Creator
-
Laviola, Luigi
Porcellati, Francesca
Bruttomesso, Daniela
Larosa, Monica
Rossi, Maria Chiara
Nicolucci, Antonio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13300-020-00982-z
- URN
-
urn:nbn:de:101:1-2021032114152828672982
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Laviola, Luigi
- Porcellati, Francesca
- Bruttomesso, Daniela
- Larosa, Monica
- Rossi, Maria Chiara
- Nicolucci, Antonio
- SpringerLink (Online service)
Other Objects (12)
Systems engineering mit SysML, UML : Modellierung, Analyse, Design
Modellierung von eingebetteten Systemen mit UML und SysML
Systems engineering mit SysML, UML : Modellierung, Analyse, Design
Systems engineering mit SysML, UML : Anforderungen, Analyse, Architektur
Switching the basal insulin to insulin glargine 300 u/ml in people with type 2 diabetes under basal insulin supported oral therapy – observational trial on effectiveness and safety
IT-Lösungen auf Basis von SysML und UML : Anwendungsentwicklung mit Eclipse UML Designer und Eclipse Papyrus
IT-Lösungen auf Basis von SysML und UML : Anwendungsentwicklung mit Eclipse UML Designer und Eclipse Papyrus
SysML UML ni yoru shisutemu enjiniaringu nyūmon : moderingu bunseki sekkei
Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study
Glycaemic control in people with type 2 diabetes mellitus switching from basal insulin to insulin glargine 300 u/ml (gla-300): results from the reali pooled database
Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec
Systems engineering mit SysML, UML : Modellierung, Analyse, Design
Modellierung von eingebetteten Systemen mit UML und SysML
Systems engineering mit SysML, UML : Modellierung, Analyse, Design
Systems engineering mit SysML, UML : Anforderungen, Analyse, Architektur
Switching the basal insulin to insulin glargine 300 u/ml in people with type 2 diabetes under basal insulin supported oral therapy – observational trial on effectiveness and safety
IT-Lösungen auf Basis von SysML und UML : Anwendungsentwicklung mit Eclipse UML Designer und Eclipse Papyrus
IT-Lösungen auf Basis von SysML und UML : Anwendungsentwicklung mit Eclipse UML Designer und Eclipse Papyrus
SysML UML ni yoru shisutemu enjiniaringu nyūmon : moderingu bunseki sekkei
Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study
Glycaemic control in people with type 2 diabetes mellitus switching from basal insulin to insulin glargine 300 u/ml (gla-300): results from the reali pooled database
Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec
Systems engineering mit SysML, UML : Modellierung, Analyse, Design
Modellierung von eingebetteten Systemen mit UML und SysML
Systems engineering mit SysML, UML : Modellierung, Analyse, Design
Systems engineering mit SysML, UML : Anforderungen, Analyse, Architektur
Switching the basal insulin to insulin glargine 300 u/ml in people with type 2 diabetes under basal insulin supported oral therapy – observational trial on effectiveness and safety
IT-Lösungen auf Basis von SysML und UML : Anwendungsentwicklung mit Eclipse UML Designer und Eclipse Papyrus
IT-Lösungen auf Basis von SysML und UML : Anwendungsentwicklung mit Eclipse UML Designer und Eclipse Papyrus
SysML UML ni yoru shisutemu enjiniaringu nyūmon : moderingu bunseki sekkei
Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study
Glycaemic control in people with type 2 diabetes mellitus switching from basal insulin to insulin glargine 300 u/ml (gla-300): results from the reali pooled database
Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database